Sirolimus-eluting stents reduce long-term mortality compared with bare metal stents in ST-segment elevation myocardial infarction: A meta-analysis of randomized controlled trials

International Journal of Cardiology

Volumn 167, Issue 1, 2013, Pages 162-167

  Sakurai, Ryota ^a   Inajima, Tsukasa ^a   Kaneda, Hideaki ^b   Nagai, Ryozo ^a   Hashimoto, Hideki ^c  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Long term follow up; Meta analysis; Randomized controlled trial; Sirolimus eluting stent; ST segment elevation myocardial infarction

Indexed keywords

RAPAMYCIN;

ARTICLE; BARE METAL STENT; DEATH; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

DRUG-ELUTING STENTS; HUMANS; METALS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878581013     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.12.054     Document Type: Article

References (44)

1. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
2. M.C. Morice, P.W. Serruys, and P. Barragan Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 50 2007 1299 1304
3. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
4. G. Weisz, M.B. Leon, and D.R. Holmes Jr. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial J Am Coll Cardiol 53 2009 1488 1497
5. J. Schofer, M. Schluter, and A.H. Gershlick Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
6. E. Schampaert, E.A. Cohen, and M. Schluter The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115
7. M.J. Suttorp, G.J. Laarman, and B.M. Rahel Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions Circulation 114 2006 921 928
8. B.M. Rahel, G.J. Laarman, J.C. Kelder, J.M. Ten Berg, and M.J. Suttorp Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study) Am Heart J 157 2009 149 155
9. D. Baumgart, V. Klauss, and F. Baer One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients J Am Coll Cardiol 50 2007 1627 1634
10. P. Jimenez-Quevedo, M. Sabate, and D.J. Angiolillo Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial Eur Heart J 28 2007 1946 1952
11. H. Kelbaek, L. Thuesen, and S. Helqvist The Stenting Coronary Arteries in Non-stress/Benestent Disease (SCANDSTENT) trial J Am Coll Cardiol 47 2006 449 455
12. H. Kelbaek, L. Klovgaard, and S. Helqvist Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial J Am Coll Cardiol 51 2008 2011 2016
13. C. Spaulding, P. Henry, and E. Teiger Sirolimus-eluting versus uncoated stents in acute myocardial infarction N Engl J Med 355 2006 1093 1104
14. M. Menichelli, A. Parma, and E. Pucci Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI) J Am Coll Cardiol 49 2007 1924 1930
15. L.S. Diaz de la Llera, S. Ballesteros, and J. Nevado Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty Am Heart J 154 2007 164.e1 164.e6
16. B.L. van der Hoeven, S.S. Liem, and J.W. Jukema Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention study J Am Coll Cardiol 51 2008 618 626
17. M. Valgimigli, G. Campo, and G. Percoco Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial JAMA 299 2008 1788 1799
18. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
19. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
20. M.J. Sweeting, A.J. Sutton, and P.C. Lambert What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data Stat Med 23 2004 1351 1375
21. M.J. Bradburn, J.J. Deeks, J.A. Berlin, and A. Russell Localio Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events Stat Med 26 2007 53 77
22. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
23. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
24. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
25. J.A. Sterne, D. Gavaghan, and M. Egger Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature J Clin Epidemiol 53 2000 1119 1129
26. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 2009 W65 W94
27. M. Valgimigli, G. Campo, and C. Arcozzi Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study J Am Coll Cardiol 50 2007 138 145
28. H. Kelbaek, L. Thuesen, and S. Helqvist Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial Circulation 118 2008 1155 1162
29. D. Yoshikawa, S. Isobe, and H. Umeda Three-year prognosis of Japanese patients with ST-elevation myocardial infarction treated with sirolimus-eluting stents Coron Artery Dis 20 2009 422 427
30. M. Valgimigli 3-year follow-up of the multicentre evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus eluting stent or bare metal stent in acute myocardial infarction study Paper presented at: European Society of Cardiology Congress 2010 August 29, 2010 Stockholm Sweden
31. C. Spaulding, E. Teiger, and P. Commeau Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty) JACC Cardiovasc Interv 4 2011 14 23
32. E. Di Lorenzo, R. Sauro, and A. Varricchio Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial Am Heart J 158 2009 e43 e50
33. J.Z. Atary, B.L. van der Hoeven, and S.S. Liem Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention study) Am J Cardiol 106 2010 4 12
34. R. Violini, C. Musto, and F. De Felice Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial J Am Coll Cardiol 55 2010 810 814
35. S.S. Brar, M.B. Leon, and G.W. Stone Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis J Am Coll Cardiol 53 2009 1677 1689
36. J. Daemen, S. Tanimoto, and H.M. Garcia-Garcia Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries) Am J Cardiol 99 2007 1027 1032
37. N. Kukreja, Y. Onuma, H. Garcia-Garcia, J. Daemen, R. van Domburg, and P.W. Serruys Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation Circ Cardiovasc Interv 1 2008 103 110
38. E.L. Hannan, M. Racz, and G. Walford Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 129 135
39. D.S. Pinto, G.W. Stone, and S.G. Ellis Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial J Am Coll Cardiol 48 2006 32 36
40. R. Michels, and I. Wijnbergen A comparison of drug eluting stents and bare metal stents with or without abciximab in ST-segment elevation myocardial Infarction, The Eindhoven Reperfusion study Paper presented at: TCT09; September 25, 2009; San Francisco, CA 2009
41. P. Juni, A. Witschi, R. Bloch, and M. Egger The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 1999 1054 1060
42. A.J. Nordmann, M. Briel, and H.C. Bucher Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis Eur Heart J 27 2006 2784 2814
43. D.R. Holmes Jr., J.W. Moses, J. Schofer, M.C. Morice, E. Schampaert, and M.B. Leon Cause of death with bare metal and sirolimus-eluting stents Eur Heart J 27 2006 2815 2822
44. E. Di Lorenzo, G. De Luca, and R. Sauro The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) randomized trial JACC Cardiovasc Interv 2 2009 515 523